Collaboration

	Antonio Cepeda-Benito, Ph.D. International Subcommittee Chair Department of Psychology Texas A & M University U.S.A.
	James Anthony, Ph.D., PDF Department of Epidemiology Michigan State University U.S.A.
	Ramon Bernabeu, Ph.D. Departmento de Biología Celular Instituto de Biología Celular Argentina
	Octavio Campollo, Ph.D. Centro de Estudios de Alcoholismo y Adicciones Universidad de Guadalajara México
	Silvia Cruz, Ph.D. Department of Pharmacobiology Cinvestav, IPN México
	Emilia Figueroa, M.D. Médico Clínica Integral de Tratamiento Contra las Adicciones, S.A. de C.V. México
	Rafael Maldonado, M.D., Ph.D. Health and Life Sciences School University Pompeu Fabra Spain
	Maria Elena Icaza Medina-Mora, Ph.D. Department of Epidemiology and Psychosocial Research Instituto Nacional de Psiquiatria Ramon de la Fuente México
	José Humberto Nicolini Sánchez,M.D., Ph.D. Plantel del Valle Universidad de la Ciudad de México México
	Augusto Pérez-Gómez, Ph.D. Department of Sociology Corporación Nuevos Rumbos Colombia
	Francisco Romero, Ph.D. Department of Physiology, Pharmacology & Toxicology Universidad Cardenal Herrera-CEU Spain
	Nelly Salgado de Snyder, Ph.D. Community Health and Social Welfare National Institute of Public Health México
	José Szapocznik, Ph.D. University of Miami Miller School of Medicine Department of Psychiatry & Behavioral Sciences U.S.A.
	Miguel Torres, M.D., Ph.D. Dirección General De Drogodependencias Generalitat Valenciana Spain
	Avelardo Valdez, Ph.D. Graduate School of Social Work Office of Drug and Social Policy Research U.S.A.
	Rodrigo Valles Jr., Ph.D. St. Kitts Biomedical Research Foundation St. Kitts
	William A. Vega, Ph.D. David Geffen School of Medicine at UCLA Department of Family Medicine U.S.A.
	Vincent Villar, Ph.D. Department of Physiology Universidad de Valencia Spain
	Fernando Antonio Wagner, Sc.D. Research Scientist Drug Abuse Research Program Center for Health Disparities Solutions Morgan State University U.S.A.